Efficacy and Tolerability of Riluzole in Treatment Resistant Depression.
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Riluzole (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 11 Jan 2018 Status changed from active, no longer recruiting to completed.
- 03 Feb 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 15 Jan 2014 According to ClinicalTrials.gov record, planned end date changed from 1 Aug 2014 to 1 Aug 2015.